Canon Stock Leads These Japanese Dividend Powerhouses With 3% Yields

Oil prices remain elevated as shipping risks around the Strait of Hormuz keep energy costs in focus. That keeps inflation on the radar and reminds income investors how helpful reliable cash payouts can feel when price levels are hard to predict. Dividend powerhouses with 3%+ yields offer a way to put steady cash flows at the center of a portfolio. This article highlights three standouts from that group.

The three stocks that follow are just a small sample, and the full Dividend Powerhouses screen surfaced 447 more companies with equally compelling income stories that are not covered in this article.

Head straight into the Dividend Powerhouses (3%+ Yield) screener to identify ideas, analyze their dividend strength, and focus on the highest conviction opportunities for your watchlist.

Canon (TSE:7751)

Overview: Canon is a Japanese technology group that develops and sells printers, medical imaging systems, cameras, and industrial equipment, supplying both homes and businesses across the globe. Its products range from office and production printers to CT and MRI machines, security cameras, semiconductor equipment, and specialist components, all sold under the Canon brand.

Operations: Canon generates most of its revenue from the Printing segment at about ¥2.5t, followed by Imaging at about ¥1.1t, Medical at about ¥579b, and Industrial at about ¥347b, with additional contributions from other corporate activities and eliminations.

Market Cap: ¥3.9t

Income investors may want to pay attention to Canon because it combines a sizeable global printing and imaging franchise with recent earnings momentum and a relatively low P/E multiple compared with peers. Net profit margins roughly doubled over the past year and the first half of 2026 showed revenue and net income both moving higher, supported by product recognition such as the Red Dot Design Award 2026 for its digital presses. At the same time, the company has been actively buying back shares in 2026, which can support earnings per share. The trade off is an unstable dividend record, questions around board independence, and reliance on external borrowing, which all matter if you are counting on Canon as a long term dividend anchor.

Canon’s earnings momentum and share buybacks are getting attention, but the real story is how those trends compare with its payout history and debt load. Get the full picture in the 4 key rewards and 1 important warning sign

Build your own Canon style dividend shortlist

Canon and the other two stocks in this article all came from a single Simply Wall St screen, but your best ideas often start with filters that match your own approach. Use our flexible Screener to mix dividend strength with valuation and risk checks, or jump straight into any of our curated Investing Ideas.

Tokio Marine Holdings (TSE:8766)

Overview: Tokio Marine Holdings is a global insurance group that offers a wide range of non life and life insurance products, reinsurance, and fee based risk solutions for individuals, businesses, and institutions across Japan, the US, and other international markets.

Operations: Tokio Marine Holdings generates most of its revenue from Overseas Insurance Business at about ¥5.2t and Domestic Property and Casualty Insurance at about ¥3.1t, with smaller contributions from Domestic Life Insurance at about ¥354b and Solution and Other Business at about ¥328b.

Market Cap: ¥14.4t

Tokio Marine Holdings stands out in this dividend focused group because it combines a 3.16% yield with a long established global franchise and active capital returns through a large buyback program that has already retired more than 38 million shares in 2026. Analysts expect earnings and margins to improve over the next few years and some see the stock trading well below their estimate of fair value, even though the current P/E is high compared with many insurance peers. That mix of income, buybacks and growth expectations comes with real tension. Profit margins recently fell from 13.2% to 6.6%, revenue growth forecasts sit below the broader market, and the balance sheet leans heavily on external borrowing, so understanding how these forces balance out is crucial for income focused investors.

Tokio Marine’s mix of 3.16% yield, heavy buybacks and a global franchise raises a bigger question. Is the current P/E masking the real story, or is the balance sheet risk hiding in plain sight in the 3 key rewards and 1 important warning sign?

Daiichi Sankyo Company (TSE:4568)

Overview: Daiichi Sankyo Company is a global pharmaceutical group based in Japan that focuses on cancer and specialty treatments, including widely used therapies such as Enhertu, Datroway, Vanflyta and a range of cardiovascular, diabetes, migraine and vaccine products.

Operations: Daiichi Sankyo Company generates essentially all of its revenue, about ¥2,223.2b, from its Pharmaceutical Operation segment.

Market Cap: ¥5.1t

Income investors looking past traditional utilities and financials may find Daiichi Sankyo Company worth a closer look. The company offers a 3.57% dividend yield alongside oncology franchises like Enhertu and Datroway, a deep antibody drug conjugate pipeline and global partnerships with groups such as AstraZeneca and Merck. Guidance has been raised for 2027 and analysts see upside relative to both their price targets and a DCF based fair value, after a year when earnings fell and the stock lagged the wider JP market. The flip side is meaningful dependence on a few blockbuster drugs, thinner profit margins than a year ago and rising R&D and funding costs, so the key question is how durable those growth engines are against regulatory and pricing pressure.

Daiichi Sankyo’s oncology engine and 3.57% yield sit at the crossroads of excitement and concentration risk. Before the story moves into its next chapter, see how the pipeline, partnerships and payout fit together in the full narrative for Daiichi Sankyo Company

Seeking Fresh Alternatives Before They Fly

Fresh stock ideas can move from under the radar to full momentum faster than many expect. Before the next breakout is caught by the crowd, review these screens and consider your options promptly.

• Spot companies quietly building strength before momentum shows on the chart by scanning the 64 high quality undiscovered gems while it still sits under the radar for now.
• Target resilient businesses when markets feel stretched by zeroing in on the 55 resilient stocks with low risk scores before defensive opportunities start dropping off your radar.
• Position ahead of potential infrastructure and energy developments by reviewing the curated 37 power grid technology and infrastructure stocks while it is still timely and before valuations shift significantly.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com